Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Global microRNA profiling of metastatic conjunctival melanoma

Research output: Contribution to journalJournal articleResearchpeer-review

  1. Evaluation of the contribution of germline variants in BRCA1 and BRCA2 to uveal and cutaneous melanoma

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Targeted ultrasound and fine-needle aspiration cytology for sentinel node diagnostics in early-stage melanoma: a validation study

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Prognostic and predictive value of YKL-40 in stage IIB-III melanoma

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Increased incidence of melanoma in situ in Denmark from 1997 to 2011: results from a nationwide population-based study

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Development and validation of a multiple-choice questionnaire-based theoretical test in direct ophthalmoscopy

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Dynamic soft tissue changes in the orbit after a blowout fracture

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Germline variants in oculocutaneous albinism genes and predisposition to familial cutaneous melanoma

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations

This study aimed to investigate the microRNA (miRNA) profile in primary tumors from conjunctival melanoma with and without subsequent metastatic spread along with their coupled distant metastases to identify miRNAs likely to be involved in metastatic progression. This observational study included 13 patients with metastatic conjunctival melanoma (follow-up: 1-39 years) treated at a Danish referral center. Twenty-five patients with nonmetastatic conjunctival melanoma (follow-up: 5-17 years) were included for comparison. Global miRNA profiling was performed with the Affymetrix GeneChip 4.1 microarray. Taqman qPCR arrays were used for validation. Significant differentially expressed miRNAs were defined as having a false discovery rate of less than 0.05. Primary conjunctival melanoma with and without subsequent metastatic spread clustered separately according to miRNA expression, and 15 miRNAs were found to have significant differential expression. Six miRNAs (hsa-miR-4528, hsa-miR-1270, hsa-miR-1290, hsa-mir-548f-4, hsa-mir-4278, and hsa-miR-34a-3p) were downregulated and nine miRNAs were upregulated (hsa-mir-575, hsa-miR-527, hsa-miR-518a-5p, hsa-miR-6759-5p, hsa-miR-8078, hsa-mir-4501, hsa-mir-622, hsa-mir-4698, and hsa-mir-4654) in primary conjunctival melanoma with subsequent metastatic spread. A comparison of primary conjunctival melanoma with their pair-matched metastases identified six significant differentially expressed miRNAs (hsa-miR-1246 and hsa-miR-302d-5p, hsa-mir-6084, hsa-miR-184, hsa-mir-658, and hsa-mir-4427). qPCR confirmed downregulation of hsa-miR-184 in the distant metastases when compared with the corresponding primary tumor. Primary conjunctival melanoma with and without subsequent metastatic spread separated clearly on the miRNA level when profiled with microarray-based methods. qPCR was able to replicate expression levels of one miRNA (hsa-miR-184) that was downregulated in metastases when compared with corresponding primary tumors.

Original languageEnglish
JournalMelanoma Research
Volume29
Issue number5
Pages (from-to)465-473
Number of pages9
ISSN0960-8931
DOIs
Publication statusPublished - Oct 2019

ID: 58938814